Charles Kummeth Purchases 500,000 Shares of Quantum-Si (NASDAQ:QSI) Stock

Quantum-Si Incorporated (NASDAQ:QSI) Director Charles Kummeth bought 500,000 shares of the business’s stock in a transaction dated Thursday, March 5th. The shares were purchased at an average price of $0.92 per share, for a total transaction of $460,000.00. Following the transaction, the director directly owned 855,000 shares of the company’s stock, valued at approximately $786,600. This represents a 140.85% increase in their position. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink.

Quantum-Si Stock Up 12.3%

Shares of NASDAQ QSI opened at $1.04 on Wednesday. The stock has a market cap of $224.11 million, a PE ratio of -2.00 and a beta of 3.00. Quantum-Si Incorporated has a 52-week low of $0.84 and a 52-week high of $3.10. The business has a 50-day moving average price of $1.09 and a 200 day moving average price of $1.37.

Quantum-Si (NASDAQ:QSI) last released its quarterly earnings results on Tuesday, March 3rd. The company reported ($0.08) EPS for the quarter, topping the consensus estimate of ($0.14) by $0.06. Quantum-Si had a negative return on equity of 43.90% and a negative net margin of 4,160.06%.The company had revenue of $0.45 million for the quarter, compared to analyst estimates of $0.76 million. Sell-side analysts anticipate that Quantum-Si Incorporated will post -0.65 earnings per share for the current year.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quantum-Si in a report on Monday, December 29th. Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $3.25.

Institutional Trading of Quantum-Si

A number of hedge funds have recently added to or reduced their stakes in the stock. Prudential Financial Inc. purchased a new position in shares of Quantum-Si in the 2nd quarter valued at approximately $25,000. Curbstone Financial Management Corp purchased a new stake in shares of Quantum-Si during the fourth quarter worth approximately $26,000. Capital Investment Advisory Services LLC lifted its holdings in shares of Quantum-Si by 100.0% during the third quarter. Capital Investment Advisory Services LLC now owns 20,000 shares of the company’s stock worth $28,000 after purchasing an additional 10,000 shares during the period. Leonteq Securities AG purchased a new position in Quantum-Si in the 4th quarter valued at $28,000. Finally, Elite Life Management LLC purchased a new position in Quantum-Si in the 3rd quarter valued at $29,000. 39.90% of the stock is owned by institutional investors and hedge funds.

About Quantum-Si

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.